Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Cost utility analysis of intra...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Cost utility analysis of intravenous tissue plasminogen activator in acute ischemic stroke in Canada
Bibliographic Details
Main Authors:
Demaerschalk, B
,
Silver, B
,
Merino, J
,
Wong, E
,
Hill, MD
,
Poncha, F
,
Foell, B
,
Tamayo, A
,
Buchan, A
,
Hachinski, V
Format:
Conference item
Published:
2003
Holdings
Description
Similar Items
Staff View
Similar Items
Does the application of X-ray contrast agents impair the clinical effect of intravenous recombinant tissue-type plasminogen activator in acute ischemic stroke patients?
by: Dzialowski, I, et al.
Published: (2012)
The Utility of Automated ASPECTS in Acute Ischemic Stroke for Intravenous Recombinant Tissue Plasminogen Activator (IV-rtPA) Therapy
by: Soichiro Shibata, et al.
Published: (2022-11-01)
Effectiveness of tissue-type plasminogen activator for acute ischemic stroke: Consequences of protocol violation
by: Karbalai, H, et al.
Published: (1999)
Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke.
by: Wang, X, et al.
Published: (2004)
Repeated Intravenous Thrombolytic Treatment Experience with Tissue Plasminogen Activator in Patients with Acute Ischemic Stroke: Case series
by: Kadriye Güleda Keskin, et al.
Published: (2023-03-01)